Previous Article |
Table of Contents
| Next Article
* Department of Microbiology and Immunology, WJ Hearst
Foundation, Weill Medical College of Cornell University, New York, NY
10021; Communicated by Lloyd J. Old, Ludwig Institute for Cancer
Research, New York, August, 10, 2001 (received for review March 5, 2001)
Tumor necrosis factor-
Immunology
TNF-
-dependent maturation of local dendritic cells is critical
for activating the adaptive immune response to virus infection
,
,
,
The Cornell-Rockefeller-Sloan-Kettering
Tri-Institutional MD-PhD Program, New York, NY 10021;
Ludwig Institute for Cancer Research,
Memorial-Sloan Kettering Cancer Center, New York, NY 10021;
§ Service de Nephrologie-Immunologie Clinique, Centre
Hospitalier Régional Universitaire de Nantes, Immeuble Jean
Monnet, 44093 Nantes Cedex 01, France; and ¶ Hospital
for Special Surgery, New York, NY 10021
(TNF-
) is well recognized for its role
in mediating innate immune responses. However, the mechanisms of
TNF-
that influence the adaptive immune response to virus infections
are not well understood. In this study, we have investigated the role
of TNF-
in activating the cellular and humoral responses to systemic
viral challenge with recombinant replication-defective adenovirus
(rAd). Evaluation of T cell function in TNF-
-deficient (TNFKO) mice
revealed impaired virus-specific proliferation of T cells derived from
the draining lymph nodes of the liver. Analysis of dendritic cells (DC)
isolated from local draining lymph nodes after systemic challenge
showed that DC from TNFKO mice were relatively immature compared with
those from strain-matched wild-type mice. In vitro,
TNF-
was required to mature DC efficiently during virus-mediated stimulation. Adoptive transfer of primed, mature DC into TNFKO mice
restored T cell responses and reconstituted anti-adenovirus antibody
responses. Thus, TNF-
plays a significant role in the maturation of
DC after adenovirus challenge both in vitro and in vivo, highlighting the importance of this innate
cytokine in activating adaptive immunity to viral challenge.
To whom reprint requests should be addressed.
E-mail: efalckp{at}med.cornell.edu.
www.pnas.org/cgi/doi/10.1073/pnas.211423598
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg What's this?
This article has been cited by other articles in HighWire Press-hosted journals:
![]() |
E. Billard, J. Dornand, and A. Gross Interaction of Brucella suis and Brucella abortus Rough Strains with Human Dendritic Cells Infect. Immun., December 1, 2007; 75(12): 5916 - 5923. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Billard, J. Dornand, and A. Gross Brucella suis Prevents Human Dendritic Cell Maturation and Antigen Presentation through Regulation of Tumor Necrosis Factor Alpha Secretion Infect. Immun., October 1, 2007; 75(10): 4980 - 4989. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chen, J. Diao, S. M. Stepkowski, and L. Zhang Both Infiltrating Regulatory T Cells and Insufficient Antigen Presentation Are Involved in Long-Term Cardiac Xenograft Survival J. Immunol., August 1, 2007; 179(3): 1542 - 1548. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nociari, O. Ocheretina, J. W. Schoggins, and E. Falck-Pedersen Sensing Infection by Adenovirus: Toll-Like Receptor-Independent Viral DNA Recognition Signals Activation of the Interferon Regulatory Factor 3 Master Regulator J. Virol., April 15, 2007; 81(8): 4145 - 4157. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Tse, M. J. Milton, S. Schreiner, J. L. Profozich, M. Trucco, and J. D. Piganelli Disruption of Innate-Mediated Proinflammatory Cytokine and Reactive Oxygen Species Third Signal Leads to Antigen-Specific Hyporesponsiveness J. Immunol., January 15, 2007; 178(2): 908 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, X. Gao, E. Masuda, P. B. Redecha, M. C. Blank, and L. Pricop Regulated Expression of Fc{gamma}R in Human Dendritic Cells Controls Cross-Presentation of Antigen-Antibody Complexes J. Immunol., December 15, 2006; 177(12): 8440 - 8447. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Wang, Y. Liu, J. Wang, G. Ding, W. Zhang, G. Chen, M. Zhang, S. Zheng, and X. Cao Induction of Allospecific Tolerance by Immature Dendritic Cells Genetically Modified to Express Soluble TNF Receptor J. Immunol., August 15, 2006; 177(4): 2175 - 2185. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Thiele, T. L. Sumpter, J. A. Walker, Q. Xu, C.-H. Chang, R. L. Bacallao, R. Kher, and D. S. Wilkes Pulmonary Immunity to Viral Infection: Adenovirus Infection of Lung Dendritic Cells Renders T Cells Nonresponsive to Interleukin-2 J. Virol., February 15, 2006; 80(4): 1826 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Schoggins, M. Nociari, N. Philpott, and E. Falck-Pedersen Influence of Fiber Detargeting on Adenovirus-Mediated Innate and Adaptive Immune Activation J. Virol., September 15, 2005; 79(18): 11627 - 11637. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sundquist and M. J. Wick TNF-{alpha}-Dependent and -Independent Maturation of Dendritic Cells and Recruited CD11cintCD11b+ Cells during Oral Salmonella Infection J. Immunol., September 1, 2005; 175(5): 3287 - 3298. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ohmura, M. Yamamoto, C. Tomiyama-Miyaji, Y. Yuki, Y. Takeda, and H. Kiyono Nontoxic Shiga Toxin Derivatives from Escherichia coli Possess Adjuvant Activity for the Augmentation of Antigen-Specific Immune Responses via Dendritic Cell Activation Infect. Immun., July 1, 2005; 73(7): 4088 - 4097. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pollara, M. Jones, M. E. Handley, M. Rajpopat, A. Kwan, R. S. Coffin, G. Foster, B. Chain, and D. R. Katz Herpes Simplex Virus Type-1-Induced Activation of Myeloid Dendritic Cells: The Roles of Virus Cell Interaction and Paracrine Type I IFN Secretion J. Immunol., September 15, 2004; 173(6): 4108 - 4119. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Philpott, M. Nociari, K. B. Elkon, and E. Falck-Pedersen Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-{alpha} induction pathway PNAS, April 20, 2004; 101(16): 6200 - 6205. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Alaniz, S. Sandall, E. K. Thomas, and C. B. Wilson Increased Dendritic Cell Numbers Impair Protective Immunity to Intracellular Bacteria Despite Augmenting Antigen-Specific CD8+ T Lymphocyte Responses J. Immunol., March 15, 2004; 172(6): 3725 - 3735. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Minagawa, K. Hashimoto, and Y. Yanagi Absence of tumour necrosis factor facilitates primary and recurrent herpes simplex virus-1 infections J. Gen. Virol., February 1, 2004; 85(2): 343 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fontana, D. Moratto, S. Mangal, M. De Francesco, W. Vermi, S. Ferrari, F. Facchetti, N. Kutukculer, C. Fiorini, M. Duse, et al. Functional defects of dendritic cells in patients with CD40 deficiency Blood, December 1, 2003; 102(12): 4099 - 4106. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Beloeil, M. Tomkowiak, G. Angelov, T. Walzer, P. Dubois, and J. Marvel In Vivo Impact of CpG1826 Oligodeoxynucleotide on CD8 T Cell Primary Responses and Survival J. Immunol., September 15, 2003; 171(6): 2995 - 3002. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chomarat, C. Dantin, L. Bennett, J. Banchereau, and A. K. Palucka TNF Skews Monocyte Differentiation from Macrophages to Dendritic Cells J. Immunol., September 1, 2003; 171(5): 2262 - 2269. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Gamadia, E. B. M. Remmerswaal, J. F. Weel, F. Bemelman, R. A. W. van Lier, and I. J. M. Ten Berge Primary immune responses to human CMV: a critical role for IFN-gamma -producing CD4+ T cells in protection against CMV disease Blood, April 1, 2003; 101(7): 2686 - 2692. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Straw, A. S. MacDonald, E. Y. Denkers, and E. J. Pearce CD154 Plays a Central Role in Regulating Dendritic Cell Activation During Infections That Induce Th1 or Th2 Responses J. Immunol., January 15, 2003; 170(2): 727 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-M. Hu, H. Winter, J. Ma, M. Croft, W. J. Urba, and B. A. Fox CD28, TNF Receptor, and IL-12 Are Critical for CD4-Independent Cross-Priming of Therapeutic Antitumor CD8+ T Cells J. Immunol., November 1, 2002; 169(9): 4897 - 4904. [Abstract] [Full Text] [PDF] |
||||